U.S. markets close in 4 hours 38 minutes
  • S&P 500

    +37.50 (+0.89%)
  • Dow 30

    +187.01 (+0.56%)
  • Nasdaq

    +161.56 (+1.26%)
  • Russell 2000

    +17.40 (+0.88%)
  • Crude Oil

    -2.01 (-2.13%)
  • Gold

    +3.10 (+0.17%)
  • Silver

    +0.14 (+0.67%)

    -0.0066 (-0.64%)
  • 10-Yr Bond

    -0.0260 (-0.90%)

    -0.0074 (-0.61%)

    +0.5810 (+0.44%)

    -556.13 (-2.28%)
  • CMC Crypto 200

    -3.76 (-0.66%)
  • FTSE 100

    +27.15 (+0.36%)
  • Nikkei 225

    +727.65 (+2.62%)

Veru Inc. (VERU) Dips More Than Broader Markets: What You Should Know

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

In the latest trading session, Veru Inc. (VERU) closed at $11.30, marking a -1.31% move from the previous day. This change lagged the S&P 500's 0.88% loss on the day. Meanwhile, the Dow lost 0.82%, and the Nasdaq, a tech-heavy index, added 0.08%.

Heading into today, shares of the company had lost 6.07% over the past month, lagging the Medical sector's loss of 4.6% and outpacing the S&P 500's loss of 8.06% in that time.

Investors will be hoping for strength from Veru Inc. as it approaches its next earnings release. On that day, Veru Inc. is projected to report earnings of -$0.18 per share, which would represent a year-over-year decline of 500%. Meanwhile, our latest consensus estimate is calling for revenue of $16.66 million, down 5.68% from the prior-year quarter.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.58 per share and revenue of $61.89 million. These totals would mark changes of -744.44% and +1.03%, respectively, from last year.

It is also important to note the recent changes to analyst estimates for Veru Inc.These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.

Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Veru Inc. is holding a Zacks Rank of #3 (Hold) right now.

The Medical - Products industry is part of the Medical sector. This group has a Zacks Industry Rank of 179, putting it in the bottom 30% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Veru Inc. (VERU) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research